Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

China flag China · Delayed Price · Currency is CNY
17.47
-0.78 (-4.27%)
Apr 29, 2026, 3:00 PM CST
-8.39%
Market Cap 3.46B
Revenue (ttm) 640.18M
Net Income (ttm) 18.17M
Shares Out 198.24M
EPS (ttm) 0.09
PE Ratio 194.11
Forward PE n/a
Dividend 0.27 (1.48%)
Ex-Dividend Date Jun 6, 2025
Volume 4,297,563
Average Volume 1,531,440
Open 17.56
Previous Close 18.25
Day's Range 17.11 - 17.59
52-Week Range 17.26 - 23.66
Beta 0.40
RSI 29.28
Earnings Date Apr 29, 2026

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Jinhua, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,118
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603896
Full Company Profile

Financial Performance

In 2025, SHA:603896's revenue was 640.18 million, a decrease of -7.45% compared to the previous year's 691.68 million. Earnings were 18.17 million, a decrease of -89.60%.

Financial Statements

News

There is no news available yet.